109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
2021 年全球疾病负担研究揭示的多囊卵巢综合征的全球负担及未来趋势：新见解
Authors Xu R, Li X, Sang L, Su L, Song L, Ren Y, Su J
Received 28 July 2025
Accepted for publication 7 October 2025
Published 16 October 2025 Volume 2025:17 Pages 3707—3720
DOI https://doi.org/10.2147/IJWH.S556627
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Vinay Kumar
Ren Xu,1,* Xinjun Li,1,* Lu Sang,1,* Luyang Su,2,* Liyun Song,1,* Yanan Ren,1,* Jianzhi Su3,*
1Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 3Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jianzhi Su, Email 18533167591@hebmu.edu.cn
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, defined by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. It is associated with infertility, metabolic abnormalities, and an increased cardiovascular risk. This study provides an updated and comprehensive analysis of PCOS burden from 1990 to 2021 using the latest Global Burden of Disease (GBD) dataset, focusing on trends, regional disparities, and future projections.
Methods: Data on the prevalence, incidence, and disability-adjusted life years (DALYs) associated with PCOS were obtained from the GBD 2021. Temporal trends were evaluated using estimated annual percentage change (EAPC). Regional disparities were examined by stratifying data according to the socio-demographic index (SDI). Age-Period-Cohort (APC) modeling was employed to investigate disease dynamics across age groups and birth cohorts, while Bayesian Age-Period-Cohort (BAPC) models were utilized to project global burden trends through 2036.
Results: In 2021, there were 65.8 million prevalent cases, 1.18 million incident cases, and 0.58 million DALYs due to PCOS globally. Middle SDI regions showed the highest growth rates in prevalence (EAPC 1.73%), incidence (EAPC 1.39%), and DALYs (EAPC 1.72%). Adolescents aged 15– 19 demonstrated the highest incidence rates, while the peak prevalence shifted to women aged 30– 34. High SDI regions had the highest age-standardized rates (ASRs), whereas Southeast Asia exhibited the most rapid growth. BAPC models forecast continued increases in PCOS burden, with prevalence projected to reach 77.87 million by 2036, though the age-standardized prevalence rate (ASPR) and age-standardized DALYs rate (ASDR) are expected to decline.
Conclusion: PCOS represents an urgent global health challenge, with rising burdens, especially in middle-income regions. Targeted and equitable interventions are essential to improve early diagnosis, raise public awareness, and mitigate long-term health and socioeconomic consequences.
Keywords: polycystic ovary syndrome, global burden of disease, socio-demographic index, age-period-cohort model, Bayesian age-period-cohort projections, incidence
1Department of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 3Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jianzhi Su, Email 18533167591@hebmu.edu.cn
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, defined by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. It is associated with infertility, metabolic abnormalities, and an increased cardiovascular risk. This study provides an updated and comprehensive analysis of PCOS burden from 1990 to 2021 using the latest Global Burden of Disease (GBD) dataset, focusing on trends, regional disparities, and future projections.
Methods: Data on the prevalence, incidence, and disability-adjusted life years (DALYs) associated with PCOS were obtained from the GBD 2021. Temporal trends were evaluated using estimated annual percentage change (EAPC). Regional disparities were examined by stratifying data according to the socio-demographic index (SDI). Age-Period-Cohort (APC) modeling was employed to investigate disease dynamics across age groups and birth cohorts, while Bayesian Age-Period-Cohort (BAPC) models were utilized to project global burden trends through 2036.
Results: In 2021, there were 65.8 million prevalent cases, 1.18 million incident cases, and 0.58 million DALYs due to PCOS globally. Middle SDI regions showed the highest growth rates in prevalence (EAPC 1.73%), incidence (EAPC 1.39%), and DALYs (EAPC 1.72%). Adolescents aged 15– 19 demonstrated the highest incidence rates, while the peak prevalence shifted to women aged 30– 34. High SDI regions had the highest age-standardized rates (ASRs), whereas Southeast Asia exhibited the most rapid growth. BAPC models forecast continued increases in PCOS burden, with prevalence projected to reach 77.87 million by 2036, though the age-standardized prevalence rate (ASPR) and age-standardized DALYs rate (ASDR) are expected to decline.
Conclusion: PCOS represents an urgent global health challenge, with rising burdens, especially in middle-income regions. Targeted and equitable interventions are essential to improve early diagnosis, raise public awareness, and mitigate long-term health and socioeconomic consequences.
Keywords: polycystic ovary syndrome, global burden of disease, socio-demographic index, age-period-cohort model, Bayesian age-period-cohort projections, incidence